Different Localization Techniques for Non-palpable Breast Lesions Comparison: a Retrospective and Multicentric Clinical Study
Localization01
A Retrospective Multicentric Clinical Study Comparing Different Techniques for Intraoperative Localization of Non-palpable Breast Lesions During Breast Conservative Surgery
1 other identifier
observational
1,064
1 country
1
Brief Summary
Breast conservative surgery (BCS) is nowadays the standard of care for patients affected by early breast lesions. Screening programmes led to an increase of non-palpable breast lesion detection rates. These patients are often eligible for BCS and an accurate preoperative localization technique for the detection of the lesion is required to guarantee a safe surgical excision. The primary goal of BCS is to obtain a complete resection of the tumor with disease-free surgical margins. The presence of tumor on surgical margins on postoperative histological examination of the specimen increases the risk of local recurrence and it requires a surgical re-excision. For all these reasons different techniques for localization of non-palpable breast lesions have been developed over time. Since '70s the wire guided localization (WGL) technique has represented the gold standard; however it has several limitations such as wire migration or fracture and patient referred discomfort related to wire placement. Over time, other techniques have been proposed, such as the radioguided occult lesion localization (ROLL), radioactive and magnetic seeds, carbon dye and ultrasound-guided preoperative localization. Currently there are several studies of comparison between the WGL and the more modern techniques. All of these data claim the effectiveness of the new "wire-free" methodics ensuring a safe surgical resection with tumor-free margins and, in some cases, a better aesthetic result. Studies of comparison between the modern techniques are limited. There is no scientific evidence of the superiority of a technique over the other. A multicentric Italian survey demonstrated that the most used localization techniques nowadays are the WGL, ROLL, the magnetic seed and the carbon dye. The aim of this retrospective study is to compare these techniques to assess their efficacy in the localization of non-palpable breast lesions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 31, 2023
CompletedFirst Submitted
Initial submission to the registry
June 27, 2023
CompletedFirst Posted
Study publicly available on registry
July 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2028
ExpectedSeptember 2, 2025
May 1, 2025
1.8 years
June 27, 2023
August 25, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Free-surgical margins
Number of surgical procedures in which surgical margins are disease-free ("no ink on tumor" for invasive cancer and margin of 2 mm for in situ-carcinoma)
6 months
Secondary Outcomes (6)
Excess breast resection
6 months
Surgery time
6 months
Hospitalization days
6 months
Complications
6 months
Reintervention
6 months
- +1 more secondary outcomes
Study Arms (4)
ROLL technique
Radioguided occult lesion localization
MAGNETIC SEED
Magnetic seed localization
WGL technique
Wire guided localization for non-palpable breast lesions
CARBON
Carbon dye localization for non-palpable breast lesions
Interventions
Breast conservative surgery after non-palpable lesion localization
Eligibility Criteria
Breast cancer patients with non-palpable breast lesion candidated for conservative surgery
You may qualify if:
- Female sex;
- Patients who underwent breast conservative surgery for non-palpable occult breast lesions;
- Intraoperative localization of breast lesion with WGL, ROLL, magnetic seed, carbon dye;
- Preoperative diagnosis on histology or cytology of borderline lesion (B3 or C3) or malignant lesion (B4-B5 or C4-C5).
You may not qualify if:
- Diagnosis of benign breast lesion, both on preoperative needle breast biopsy (B2) or on fine needle breast aspiration (C2);
- Clinically palpable breast lesion;
- Localization of a non-palpable lesion through two or more different techniques;
- Breast tumor localization with clip in patients who underwent neoadjuvant chemotherapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istituti Clinici Scientifici Maugeri SpA
Pavia, Lombardy, 27100, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 27, 2023
First Posted
July 12, 2023
Study Start
May 31, 2023
Primary Completion
March 30, 2025
Study Completion (Estimated)
September 30, 2028
Last Updated
September 2, 2025
Record last verified: 2025-05